Malka, Nathan
Abulizi, Mukedaisi
Kharoubi, Mounira
Oghina, Silvia
Galat, Arnault
Le Bras, Fabien
Moktefi, Anissa
Guendouz, Soulef
Molinier-Frenkel, Valérie
Fanen, Pascale
Funalot, Benoît
Lefaucheur, Jean-Pascal
Blanc-Durand, Paul
Deux, Jean-François
Audard, Vincent
Bodez, Diane
Itti, Emmanuel http://orcid.org/0000-0003-1578-4058
Damy, Thibaud
Article History
Received: 9 January 2020
Accepted: 3 March 2020
First Online: 10 March 2020
Compliance with ethical standards
:
: Dr. Abulizi received a travel grant from GE Healthcare. Dr. Oghina received research grants from Pfizer. Dr. Funalot received honoraria and travel grants from Alnylam, Sanofi-Genzyme, and Pfizer. Dr. Bodez received honoraria from Alnylam and travel grants from Pfizer, Servier, and Novartis. Dr. Damy received research grants, financial grants (honoraria and speaking), and travel grants from Alnylam, GSK, AKCEA-Ionis, Pfizer, and Prothena. All other authors declare that they have no conflicts of interest.
: The study was conducted in accordance with the Helsinki declarations. All patients signed an informed written consent form. The study protocol was approved by our local ethics committee (CPP Ile-de-France IX, Créteil) and by the National Computer and Freedom Committee (CNIL - number 1431858). The data collection was approved by the Direction Régionale de la Recherche Clinique Ile-de-France (DC 2009-930).